









Markets
/
Stocks
/
nasdaq-krro
/

Korro Bio Inc

KRRO

8.120USD

-0.290-3.45%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

76.31MMarket Cap

LossP/E TTM



Korro Bio Inc

8.120

-0.290-3.45%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Korro Bio Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-6.75%-17.18M

-31.76%-19.23M

-11.70%-24.45M

---7.50M

---16.09M

---14.59M

---21.89M

Net income from continuing operations

13.99%-18.06M

-18.07%-25.77M

-19.58%-23.39M

---21.20M

---21.00M

---21.83M

---19.56M

Operating gains losses

36.30%1.18M

70.18%1.23M

68.73%1.23M

--1.25M

--865.00K

--721.00K

--726.00K

Other non-cash items

177.98%131.00K

-90.63%88.00K

-115.13%-182.00K

---440.00K

---168.00K

--939.00K

--1.20M

Change in working capital

-176.74%-2.25M

-31.65%3.15M

24.55%-3.87M

--11.18M

--2.94M

--4.61M

---5.13M

-Change in receivables

--269.00K

--835.00K

---228.00K

---1.70M

----

-Change in prepaid expenses

-48.70%256.00K

115.61%172.00K

-112.76%-617.00K

--167.00K

--499.00K

---1.10M

---290.00K

-Change in other current assets

134.48%136.00K

-138.37%-33.00K

-572.09%-406.00K

--110.00K

--58.00K

--86.00K

-Change in other current liabilities

---271.00K

---371.00K

---626.00K

--9.43M

----

Cash from non-recurring investing activities

Cash from operating activities

-6.75%-17.18M

-31.76%-19.23M

-11.70%-24.45M

---7.50M

---16.09M

---14.59M

---21.89M

Investing cash flow

Net cash from continuing investing activities

-96.41%175.00K

-97.65%140.00K

-97.88%119.00K

--1.45M

--4.88M

--5.96M

--5.61M

Capital expenditures

-96.41%175.00K

-97.65%140.00K

-97.88%119.00K

--1.45M

--4.88M

--5.96M

--5.61M

Net cash flow from disposal of fixed assets

-96.41%175.00K

-97.65%140.00K

-97.88%119.00K

--1.45M

--4.88M

--5.96M

--5.61M

Net cash flow from investment products

200.92%7.77M

88.43%-11.16M

--32.90M

---1.31M

---7.70M

---96.43M

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

160.39%7.60M

88.96%-11.30M

684.23%32.78M

---2.77M

---12.58M

---102.39M

---5.61M

Financing cash flow

Cash flow from continuous financing activities

-82.42%128.00K

-99.99%5.00K

23.74%172.00K

--932.00K

--728.00K

--67.56M

--139.00K

Net cash flow from common stock issuance/repurchase

--0.00

----

--1.00K

--0.00

--67.38M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

Proceeds from stock option exercised by employees

-82.42%128.00K

-97.09%5.00K

23.74%172.00K

--931.00K

--728.00K

--172.00K

--139.00K

Net cash flow from other financing activities

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-82.42%128.00K

-99.99%5.00K

23.74%172.00K

--932.00K

--728.00K

--67.56M

--139.00K

Net cash flow

Beginning cash balance

-61.57%37.02M

-53.66%67.55M

-65.89%59.05M

--68.38M

--96.32M

--145.76M

--173.12M

Current period cash flow changes

66.16%-9.46M

38.23%-30.53M

131.07%8.50M

---9.33M

---27.94M

---49.43M

---27.36M

Effect of exchange rate changes

-200.00%-2.00K

---9.00K

----

---6.00K

--2.00K

----

Ending cash balance

-59.69%27.56M

-61.57%37.02M

-53.66%67.55M

--59.05M

--68.38M

--96.33M

--145.76M

Free cash flow

17.25%-17.35M

5.77%-19.37M

10.66%-24.57M

---8.95M

---20.97M

---20.55M

---27.50M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

